Balanced news tone
News Sentiment
ALZCUR sentiment intelligence
AlzeCure Pharma AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-19.6% over one week, +43.9% over four weeks, trend active, and materially above fair value.
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics, says Jefferies
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics, says Jefferies
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jul 2026 12:37
- Source
- Proactive
AlzeCure shares hit highest since 2022 on $2.2 bln Alzheimer’s drug licensing deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- Investing.com
Final outcome of AlzeCure’s rights issue
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- TradingView
The subscription period in AlzeCure Pharma's Rights Issue begins today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- TradingView
AlzeCure Pharma (ALZCUR) Stock Surges 301% After Eli Lilly Alzheimer’s Deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- CoinCentral
AlzeCure Pharma stock surges 301% on Eli Lilly deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- Investing.com
AlzeCure Pharma exponential on Eli Lilly licensing deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- marketscreener.com
AlzeCure Pharma (ALZCUR) Stock Jumps Over 300% on Eli Lilly Partnership
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- Blockonomi
AlzeCure Pharma (ALZCUR) Stock Soars 301% Following Eli Lilly Partnership Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- parameter.io